|
SEMA4D expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63558055987778E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.5860000524579E-09 |
| Normal-vs-Stage2 |
5.76410030816987E-10 |
| Normal-vs-Stage3 |
8.94440077559011E-11 |
| Normal-vs-Stage4 |
4.73743266837801E-12 |
| Stage1-vs-Stage2 |
1.244040E-02 |
| Stage1-vs-Stage3 |
3.302000E-03 |
| Stage1-vs-Stage4 |
1.372400E-04 |
| Stage2-vs-Stage3 |
8.334400E-01 |
| Stage2-vs-Stage4 |
2.910800E-01 |
| Stage3-vs-Stage4 |
1.528560E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.53970000585468E-09 |
| Normal-vs-AfricanAmerican |
3.221800E-04 |
| Normal-vs-Asian |
4.31409999945842E-08 |
| Caucasian-vs-AfricanAmerican |
6.149600E-01 |
| Caucasian-vs-Asian |
9.320800E-01 |
| AfricanAmerican-vs-Asian |
5.988600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.33860000861574E-09 |
| Normal-vs-Female |
2.28495000698103E-12 |
| Male-vs-Female |
5.863400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.76110000418939E-08 |
| Normal-vs-Age(41-60Yrs) |
9.22619980414652E-10 |
| Normal-vs-Age(61-80Yrs) |
4.56046311825276E-12 |
| Normal-vs-Age(81-100Yrs) |
1.015950E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.053220E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.232100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.979200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.513600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.943000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.147800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.41559999999874E-06 |
| Classical-VS-Follicular |
5.062200E-01 |
| Classical-VS-Other |
8.798400E-01 |
| Classical-VS-Normal |
7.74999997510406E-09 |
| Tall-VS-Follicular |
3.475600E-03 |
| Tall-VS-Other |
2.599400E-01 |
| Tall-VS-Normal |
1.67654778948645E-12 |
| Follicular-VS-Other |
7.036800E-01 |
| Follicular-VS-Normal |
6.02699999907585E-08 |
| Other-VS-Normal |
3.502500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.61610000118884E-09 |
| Normal-vs-N1 |
3.61899399337062E-12 |
| N0-vs-N1 |
2.202500E-04 |
|
|
